What Kraig Biocraft Laboratories Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rice Jonathan Richard | Chief Operating Officer | May 27 | In/At-money Exercise · X | +314,636 | $0.08 | +$26.1K | 5,692,836 |
| Thompson Kimberly Kraig | Chief Executive Officer | Mar 31 | Will/Inheritance · W | +62,500 | $0.09 | +$5.66K | 201,650,422 |
| Thompson Kimberly Kraig | Chief Executive Officer | Mar 31 | Will/Inheritance · W | +27,500 | $0.09 | +$2.49K | 201,677,922 |
| Thompson Kimberly Kraig | CEO & CFO | Jul 20 | Disclosed 10b5-1 sale · S | −120,000 | — | — | 201,587,924 |
| Thompson Kimberly Kraig | CEO & CFO | Jul 19 | Disclosed 10b5-1 sale · S | −50,000 | — | — | 201,707,924 |
| Thompson Kimberly Kraig | CEO & CFO | Jul 18 | Disclosed 10b5-1 sale · S | −79,900 | — | — | 201,757,924 |
| Thompson Kimberly Kraig | CEO & CFO | Jul 15 | Disclosed 10b5-1 sale · S | −50,000 | — | — | 201,837,824 |
| Thompson Kimberly Kraig | CEO & CFO | Jul 13 | Disclosed 10b5-1 sale · S | −11,500 | — | — | 201,887,824 |
| Thompson Kimberly Kraig | CEO & CFO | Jul 11 | Disclosed 10b5-1 sale · S | −100,000 | — | — | 201,899,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jul 08 | Disclosed 10b5-1 sale · S | −40,000 | — | — | 201,999,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jul 07 | Disclosed 10b5-1 sale · S | −20,000 | — | — | 202,039,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jul 06 | Disclosed 10b5-1 sale · S | −60,000 | — | — | 202,059,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jul 05 | Disclosed 10b5-1 sale · S | −20,000 | — | — | 202,119,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jun 29 | Disclosed 10b5-1 sale · S | −20,000 | — | — | 202,139,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jun 28 | Disclosed 10b5-1 sale · S | −30,000 | — | — | 202,159,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jun 27 | Disclosed 10b5-1 sale · S | −50,000 | — | — | 202,189,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jun 24 | Disclosed 10b5-1 sale · S | −30,000 | — | — | 202,239,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jun 23 | Disclosed 10b5-1 sale · S | −80,000 | — | — | 202,269,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jun 22 | Disclosed 10b5-1 sale · S | −30,000 | — | — | 202,349,324 |
| Thompson Kimberly Kraig | CEO & CFO | Jun 21 | Disclosed 10b5-1 sale · S | −180,000 | — | — | 202,379,324 |
Loading...
